Phase 1/2 Study of Atrasentan Combined with Pegylated Liposomal Doxorubicin in Platinum-Resistant Recurrent Ovarian Cancer

Por Witteveen, Petronella O, van der Mijn, Koen JC, Los, Maartje, Kronemeijer, Roelien H, Groenewegen, Gerard, Voest, Emile E
Publicado em 2010